Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of the Omnipod 5 System Compared to Pump Therapy in the Treatment of Type 1 Diabetes: a Randomized, Parallel-group Clinical Trial

NCT05409131 is registered in ClinicalTrials.gov with Insulet Corporation as lead sponsor.

NCT NCT05409131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05409131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of the Omnipod 5 System Compared to Pump Therapy in the Treatment of Type 1 Diabetes: a Randomized, Parallel-group Clinical Trial
Lead sponsor
Insulet Corporation
Phase
Not applicable
Overall status
Completed
Start date
July 7, 2022
Completion date
January 10, 2025
Enrollment
196 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes